Oct 21 (Reuters) - AstraZeneca said on Wednesday the US Food and Drug Administration granted accelerated approval for its ...
3don MSN
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
Oct 20 (Reuters) - The US FDA said on Tuesday it had approved British drugmaker GSK's hepatitis B drug Hibsago, allowing ...
Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, ...
The new targeted therapy is designed to block KRAS, a protein that drives many pancreatic cancers, and its approval underscores the importance of clinical trials in advancing treatment options.
GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods ...
Uncertainties about the benefits and harms of new drugs are common at the time of drugs’ approval. It is unclear to what extent the Food and Drug Administration (FDA) communicates these uncertainties ...
Jefferies has reiterated its 'buy' rating on GSK PLC (LSE:GSK, NYSE:GSK), the pharmaceutical company, with a 2,500p price target after US regulators approved its hepatitis B treatment, Hibsago. The ...
Months after the FDA rejected its treatment for a rare light-sensitivity disease, the biotech claimed success in a Phase 3 ...
Thousands of compounded veterinary medication listings are under recall over concerns about drug potency. This week’s veterinary news also includes the first confirmed New World screwworm detection in ...
Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results